Portfolio

Our diverse portfolio includes disruptive ventures with disruptive solutions that fundamentally drive transformation and deliver value across the industry.
A financial risk prediction and cost savings tool to address polypharmacy issues.

Exits

Acquired by 1-800 Contacts | 2019
Acquired by Stryker | 2019
Acquired by Palo Alto Networks | 2019
Aquired by TransEnterix | 2018
Acquired by Thoratec | 2014